Compare IPHA & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPHA | MNSB |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 164.1M |
| IPO Year | 2014 | 2017 |
| Metric | IPHA | MNSB |
|---|---|---|
| Price | $1.91 | $25.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 52.7K | 27.8K |
| Earning Date | 03-26-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | N/A | ★ 210.00 |
| EPS | N/A | ★ 1.05 |
| Revenue | N/A | ★ $135,615,000.00 |
| Revenue This Year | $180.36 | $1.50 |
| Revenue Next Year | N/A | $3.77 |
| P/E Ratio | ★ N/A | $24.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.18 | $17.86 |
| 52 Week High | $2.71 | $25.87 |
| Indicator | IPHA | MNSB |
|---|---|---|
| Relative Strength Index (RSI) | 41.28 | 55.08 |
| Support Level | $1.67 | $23.58 |
| Resistance Level | $1.95 | $25.25 |
| Average True Range (ATR) | 0.08 | 0.56 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 0.00 | 57.14 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.